Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kay M. Ristow
Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Statin Use and Prognosis in 12,865 Non-Hodgkin Lymphoma Patients Treated in the Rituximab-Era
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Assessment Index of Clinical Transformation From Follicular Lymphoma (Fl) to Diffuse Large B-Cell Lymphoma (Dlbcl) in the Rituximab Era
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era
Blood
Biochemistry
Immunology
Cell Biology
Hematology
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising From Follicular Lymphoma in Asian Patients Treated in the Rituximab Era
Scientific Reports
Multidisciplinary
The Rituximab Maintenance Therapy Improves Prognosis of Transformed Diffuse Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Multicentre Study of Primary Breast Diffuse Large B-Cell Lymphoma in the Rituximab Era
British Journal of Haematology
Hematology
Population Pharmacokinetics of Rituximab in Patients With Diffuse Large B-Cell Lymphoma and Association With Clinical Outcome
British Journal of Clinical Pharmacology
Pharmacology
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Safety and Activity of Ibrutinib in Combination With Durvalumab in Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B‐cell Lymphoma
American Journal of Hematology
Hematology
